September 2024, Vol 5, No 3

Dr Bardeesy has contributed significantly to understanding and treating CCA, a rare and aggressive cancer of the bile ducts. He has worked with the Cholangiocarcinoma Foundation (CCF) in multiple capacities, is a CCF Science and Medical Advisory Board emeritus member, and is currently participating in the Cure Cholangiocarcinoma Think Tank (C²T²).